RU94045130A - Использование спинового улавливателя в косметической или дерматологической композиции и косметическая или дерматологическая композиция на его основе - Google Patents

Использование спинового улавливателя в косметической или дерматологической композиции и косметическая или дерматологическая композиция на его основе

Info

Publication number
RU94045130A
RU94045130A RU94045130/14A RU94045130A RU94045130A RU 94045130 A RU94045130 A RU 94045130A RU 94045130/14 A RU94045130/14 A RU 94045130/14A RU 94045130 A RU94045130 A RU 94045130A RU 94045130 A RU94045130 A RU 94045130A
Authority
RU
Russia
Prior art keywords
cosmetic
dermatologic
spin
catcher
basis
Prior art date
Application number
RU94045130/14A
Other languages
English (en)
Other versions
RU2139038C1 (ru
Inventor
Рибье Ален
Fr]
Нгийан-Канг Лан
Симонне Жан-Тьерри
Буссуира Будиаф
Original Assignee
Л'Ореаль (FR)
Л'Ореаль
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Л'Ореаль (FR), Л'Ореаль filed Critical Л'Ореаль (FR)
Publication of RU94045130A publication Critical patent/RU94045130A/ru
Application granted granted Critical
Publication of RU2139038C1 publication Critical patent/RU2139038C1/ru

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/778—Nanostructure within specified host or matrix material, e.g. nanocomposite films
    • Y10S977/78—Possessing fully enclosed nanosized voids or physical holes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к использованию в косметической или дерматологической композиции спинового улавливателя, применяемого в качестве стандартного образца для электронного парамагнитного резонанса для обработки кожи с целью защиты от света, для предотвращения старения и/или образования угрей. В частности, этот спиновый улавливатель капсулируется в липидных пузырьках, которые могут диффундировать в глубокие слои кожи.

Claims (1)

  1. Изобретение относится к использованию в косметической или дерматологической композиции спинового улавливателя, применяемого в качестве стандартного образца для электронного парамагнитного резонанса для обработки кожи с целью защиты от света, для предотвращения старения и/или образования угрей. В частности, этот спиновый улавливатель капсулируется в липидных пузырьках, которые могут диффундировать в глубокие слои кожи.
RU94045130A 1993-12-30 1994-12-29 Использование акцептора спинов в косметической или дерматологической композиции и косметическая или дерматологическая композиция на его основе RU2139038C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9315869 1993-12-30
FR9315869A FR2714604B1 (fr) 1993-12-30 1993-12-30 Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.

Publications (2)

Publication Number Publication Date
RU94045130A true RU94045130A (ru) 1996-10-20
RU2139038C1 RU2139038C1 (ru) 1999-10-10

Family

ID=9454572

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045130A RU2139038C1 (ru) 1993-12-30 1994-12-29 Использование акцептора спинов в косметической или дерматологической композиции и косметическая или дерматологическая композиция на его основе

Country Status (13)

Country Link
US (2) US5569663A (ru)
EP (1) EP0665003B1 (ru)
JP (1) JP2736312B2 (ru)
CN (1) CN1114876A (ru)
AT (1) ATE141782T1 (ru)
BR (1) BR9405479A (ru)
CA (1) CA2138877A1 (ru)
DE (1) DE69400431T2 (ru)
ES (1) ES2094035T3 (ru)
FR (1) FR2714604B1 (ru)
HU (1) HUT71385A (ru)
PL (1) PL306581A1 (ru)
RU (1) RU2139038C1 (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
AU720476B2 (en) * 1996-05-07 2000-06-01 Eric F. Bernstein Use of tempol in the prevention of photoaging
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
CA2377621C (en) * 1999-06-23 2009-05-19 Eric F. Bernstein Use of nitroxides in wound healing and in the prevention of photodamage
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US20080091179A1 (en) * 1999-12-10 2008-04-17 Candela Corporation Compact, handheld device for home-based acne treatment
US20030036749A1 (en) * 1999-12-10 2003-02-20 Durkin Anthony J. Method of treating disorders associated with sebaceous follicles
US6743222B2 (en) 1999-12-10 2004-06-01 Candela Corporation Method of treating disorders associated with sebaceous follicles
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US20030045461A1 (en) * 2001-09-06 2003-03-06 Jen-Chang Hsia Composition and methods of esterified nitroxides gated with carboxylic acids
JP4012058B2 (ja) 2001-12-21 2007-11-21 キヤノン株式会社 リサイクル性重合体、その製造方法、ならびにリサイクル処理方法
FR2846968B1 (fr) * 2002-11-08 2005-02-04 Salles Jean Pierre Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert- butyl nitrone
DE602005022616D1 (de) * 2004-12-22 2010-09-09 Basf Se Mittel gegen radikale
US20060235370A1 (en) * 2005-04-04 2006-10-19 Oblong John E Method of regulating mammalian keratinous tissue
EP1948145A2 (en) * 2005-10-24 2008-07-30 Ciba Holding Inc. Protection of oxidizable agents
EP1978919B1 (en) * 2005-12-15 2010-02-17 Greci, Lucedio Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
FR2903012A1 (fr) * 2006-06-29 2008-01-04 Arkema France Utilisation d'un polynitroxyde pour lutter contre les desordes cutane lies aux radicaux libres
EP2785316B1 (en) * 2011-11-30 2019-06-19 Dow Global Technologies LLC Nitrone compounds for use as antioxidant in personal care
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315991A1 (fr) * 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
JPS5850883A (ja) * 1981-09-21 1983-03-25 Sony Corp 分離フイルタ
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US4863717A (en) * 1986-11-10 1989-09-05 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging
US4849346A (en) * 1987-02-12 1989-07-18 Regents Of The University Of Minnesota Method for determining thioredoxin reductase activity
JP2554880B2 (ja) * 1987-05-07 1996-11-20 ポーラ化成工業株式会社 皮膚化粧料
FR2655540B1 (fr) * 1989-12-13 1994-02-11 Oreal Composition cosmetique pour le soin des cheveux et utilisation de ladite composition.
US5334756A (en) * 1991-03-26 1994-08-02 Sandoz Ltd. Carboxylate of certain polyoxyalkylene amines
AU660033B2 (en) * 1991-05-23 1995-06-08 Imarx Pharmaceutical Corp. Liposoluble compounds for magnetic resonance imaging
FR2687913A1 (fr) * 1992-02-28 1993-09-03 Oreal Composition pour traitement topique contenant des vesicules lipidiques encapsulant au moins une eau minerale.
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.

Also Published As

Publication number Publication date
US5679691A (en) 1997-10-21
CA2138877A1 (fr) 1995-07-01
RU2139038C1 (ru) 1999-10-10
US5569663A (en) 1996-10-29
PL306581A1 (en) 1995-07-10
CN1114876A (zh) 1996-01-17
FR2714604A1 (fr) 1995-07-07
EP0665003A1 (fr) 1995-08-02
BR9405479A (pt) 1995-09-19
DE69400431T2 (de) 1997-01-16
JP2736312B2 (ja) 1998-04-02
EP0665003B1 (fr) 1996-08-28
ES2094035T3 (es) 1997-01-01
JPH07324028A (ja) 1995-12-12
FR2714604B1 (fr) 1996-01-26
ATE141782T1 (de) 1996-09-15
HUT71385A (en) 1995-11-28
DE69400431D1 (de) 1996-10-02

Similar Documents

Publication Publication Date Title
RU94045130A (ru) Использование спинового улавливателя в косметической или дерматологической композиции и косметическая или дерматологическая композиция на его основе
RU94045127A (ru) Депигментирующая композиция и способ депигментации кожи
US5910311A (en) Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it
CA2005846A1 (en) Skin treatment method
RU94045129A (ru) Состав для похудения для местного применения, содержащий два типа липосом, и способ уменьшения и/или устранения полноты и/или избыточного веса
RU95105887A (ru) Косметические фильтрующие композиции и их применение
RU94045258A (ru) Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
RU94045136A (ru) Композиция для ухода за кожей, способ ухода за кожей
ATE212827T1 (de) Abschuppende zusammensetzung von salicylsäure und zwitterionischen verbindungen
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l&#39;acide salicylique ou un derive d&#39;acide salicylique et son utilisation
CA2102515A1 (en) Composition and method of enhancing sun tanning
BR9810062A (pt) Composição cosmética contendo um agente alvejante, bem como uso de uma fonte de água em combinação com a mesma
RU94031898A (ru) Косметическая или дерматологическая композиция
DK0447318T3 (da) Præparat til kosmetisk og/eller farmaceutisk behandling af de øvre lag af epidermis ved topisk applikation til huden og tilsvarende fremgansmåde til fremstilling
BR0204979A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado
ATE249819T1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
KR930021181A (ko) 화장제 조성물
RU95103967A (ru) Косметическая композиция, способ ее получения и способ косметической обработки
AR003589A1 (es) Utilizacion de una cantidad eficaz de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento destinada paratratar la inflamacion, y un procedimiento de tratamiento cosmetico mediante una composicion cosmetica que contiene a dicho peptido.
RU95102782A (ru) Косметические композиции для местного применения, вызывающие искусственный загар, способ их получения и применение
RU95106487A (ru) Применение гуаровой смолы, косметический состав и способ придания формы кератиновым волокнам
RU95103437A (ru) Косметическая и/или дерматологическая композиция и способ борьбы с внутренним старением кожи
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
BR9711649A (pt) Processo e agente para a modelagem permanente de fibras de queratina